BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 19862481)

  • 21. Pitfalls in soft tissue sarcoma imaging: chronic expanding hematomas.
    Jahed K; Khazai B; Umpierrez M; Subhawong TK; Singer AD
    Skeletal Radiol; 2018 Jan; 47(1):119-124. PubMed ID: 28887645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sarcoma.
    Ceyssens S; Stroobants S
    Methods Mol Biol; 2011; 727():191-203. PubMed ID: 21331935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histological grading and MIB-1 labeling index of soft-tissue sarcomas.
    Hasegawa T
    Pathol Int; 2007 Mar; 57(3):121-5. PubMed ID: 17295643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of repeated F-18 fluorodeoxyglucose imaging in management of patients with bone and soft tissue sarcoma.
    el-Zeftawy H; Heiba SI; Jana S; Rosen G; Salem S; Santiago JF; Abdel-Dayem HM
    Cancer Biother Radiopharm; 2001 Feb; 16(1):37-46. PubMed ID: 11279796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence, investigations and staging of soft-tissue sarcoma.
    Rock MG
    Can J Surg; 1988 Nov; 31(6):385-9. PubMed ID: 3179847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proximal-type epithelioid sarcoma of the scrotum: 18F-FDG PET/CT imaging.
    Nguyen VX; Nguyen BD
    Clin Nucl Med; 2013 Jan; 38(1):e45-7. PubMed ID: 23242066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. F-18 FDG-PET for detection of osseous metastatic disease and staging, restaging, and monitoring response to therapy of musculoskeletal tumors.
    Peterson JJ
    Semin Musculoskelet Radiol; 2007 Sep; 11(3):246-60. PubMed ID: 18260035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epithelioid sarcoma with muscle metastasis detected by positron emission tomography.
    Sakamoto A; Jono O; Hirahashi M; Oya M; Iwamoto Y; Arai K
    World J Surg Oncol; 2008 Aug; 6():84. PubMed ID: 18706085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic role of simultaneous PET/MRI-MRS in soft tissue sarcoma metabolism imaging.
    Zhang X; Chen YL; Lim R; Huang C; Chebib IA; El Fakhri G
    Magn Reson Imaging; 2016 Apr; 34(3):276-9. PubMed ID: 26523656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical evaluation of soft tissue tumors.
    Balach T; Stacy GS; Haydon RC
    Radiol Clin North Am; 2011 Nov; 49(6):1185-96, vi. PubMed ID: 22024294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of FDG positron emission tomography in conjunction with MR imaging for evaluating therapy response in patients with musculoskeletal sarcomas.
    Bredella MA; Caputo GR; Steinbach LS
    AJR Am J Roentgenol; 2002 Nov; 179(5):1145-50. PubMed ID: 12388489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma.
    Folpe AL; Lyles RH; Sprouse JT; Conrad EU; Eary JF
    Clin Cancer Res; 2000 Apr; 6(4):1279-87. PubMed ID: 10778952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current utilities of imaging in grading musculoskeletal soft tissue sarcomas.
    Fisher SM; Joodi R; Madhuranthakam AJ; Öz OK; Sharma R; Chhabra A
    Eur J Radiol; 2016 Jul; 85(7):1336-44. PubMed ID: 27235882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET.
    Jones DN; McCowage GB; Sostman HD; Brizel DM; Layfield L; Charles HC; Dewhirst MW; Prescott DM; Friedman HS; Harrelson JM; Scully SP; Coleman RE
    J Nucl Med; 1996 Sep; 37(9):1438-44. PubMed ID: 8790188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-operative core biopsy of soft-tissue tumours facilitates their surgical management.
    Serpell JW; Pitcher ME
    Aust N Z J Surg; 1998 May; 68(5):345-9. PubMed ID: 9631907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensity of FDG uptake is not everything: synchronous liposarcoma and fibrous dysplasia in the same patient on FDG PET-CT imaging.
    Charest M; Singnurkar A; Hickeson M; Novales JA; Derbekyan V
    Clin Nucl Med; 2008 Jul; 33(7):455-8. PubMed ID: 18580228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective evaluation of soft tissue masses and sarcomas using fluorodeoxyglucose positron emission tomography.
    Lucas JD; O'Doherty MJ; Cronin BF; Marsden PK; Lodge MA; McKee PH; Smith MA
    Br J Surg; 1999 Apr; 86(4):550-6. PubMed ID: 10215835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non Lipomatous Benign Lesions Mimicking Soft-tissue Sarcomas: A Pictorial Essay.
    Coran A; Orsatti G; Crimì F; Rastrelli M; DI Maggio A; Ponzoni A; Attar S; Stramare R
    In Vivo; 2018; 32(2):221-229. PubMed ID: 29475903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Surgery for soft-tissue sarcomas of the limbs and trunk wall].
    Stoeckle E; Michot A; Henriques B; Sargos P; Honoré C; Ferron G; Meeus P; Babre F; Bonvalot S
    Cancer Radiother; 2016 Oct; 20(6-7):657-65. PubMed ID: 27599681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patients.
    Walter F; Federman N; Apichairuk W; Nelson S; Phelps ME; Allen-Auerbach M; Walter MA; Czernin J
    Pediatr Hematol Oncol; 2011 Oct; 28(7):579-87. PubMed ID: 21936620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.